Suppr超能文献

载脂蛋白 C 在戈谢病中的作用。

The role of saposin C in Gaucher disease.

机构信息

Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-3708, USA.

出版信息

Mol Genet Metab. 2012 Jul;106(3):257-63. doi: 10.1016/j.ymgme.2012.04.024. Epub 2012 May 5.

Abstract

Saposin C is one of four homologous proteins derived from sequential cleavage of the saposin precursor protein, prosaposin. It is an essential activator for glucocerebrosidase, the enzyme deficient in Gaucher disease. Gaucher disease is a rare autosomal recessive lysosomal storage disorder caused by mutations in the GBA gene that exhibits vast phenotypic heterogeneity, despite its designation as a "simple" Mendelian disorder. The observed phenotypic variability has led to a search for disease modifiers that can alter the Gaucher phenotype. The PSAP gene encoding saposin C is a prime candidate modifier for Gaucher disease. In humans, saposin C deficiency due to mutations in PSAP results in a Gaucher-like phenotype, despite normal in vitro glucocerebrosidase activity. Saposin C deficiency has also been shown to modify phenotype in one mouse model of Gaucher disease. The role of saposin C as an activator required for normal glucocerebrosidase function, and the consequences of saposin C deficiency are described, and are being explored as potential modifying factors in patients with Gaucher disease.

摘要

脑苷脂激活蛋白 C 是由脑苷脂激活蛋白前体蛋白连续切割产生的四种同源蛋白之一。它是葡萄糖脑苷脂酶的必需激活剂,葡萄糖脑苷脂酶是戈谢病中缺乏的酶。戈谢病是一种罕见的常染色体隐性溶酶体贮积症,由 GBA 基因突变引起,尽管被指定为“简单”孟德尔疾病,但表现出巨大的表型异质性。观察到的表型变异性促使人们寻找可以改变戈谢病表型的疾病修饰因子。编码脑苷脂激活蛋白 C 的 PSAP 基因是戈谢病的主要候选修饰因子。在人类中,由于 PSAP 基因突变导致脑苷脂激活蛋白 C 缺乏,尽管体外葡萄糖脑苷脂酶活性正常,但会导致类似戈谢病的表型。脑苷脂激活蛋白 C 缺乏也已被证明可修饰戈谢病的一种小鼠模型的表型。脑苷脂激活蛋白 C 作为正常葡萄糖脑苷脂酶功能所必需的激活剂的作用及其缺乏的后果已被描述,并正在作为戈谢病患者的潜在修饰因子进行探索。

相似文献

1
The role of saposin C in Gaucher disease.
Mol Genet Metab. 2012 Jul;106(3):257-63. doi: 10.1016/j.ymgme.2012.04.024. Epub 2012 May 5.
3
Non-neuronopathic Gaucher disease due to saposin C deficiency.
Clin Genet. 2007 Dec;72(6):538-42. doi: 10.1111/j.1399-0004.2007.00899.x. Epub 2007 Oct 7.
4
A Type 3 Gaucher-Like Disease Due To Saposin C Deficiency in Two Emirati Families Caused by a Novel Splice Site Variant in the PSAP Gene.
J Mol Neurosci. 2022 Jun;72(6):1322-1333. doi: 10.1007/s12031-022-01987-y. Epub 2022 Mar 22.
5
Deficiency of Glucocerebrosidase Activity beyond Gaucher Disease: PSAP and LIMP-2 Dysfunctions.
Int J Mol Sci. 2024 Jun 16;25(12):6615. doi: 10.3390/ijms25126615.
6
A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity.
Hum Genet. 2005 Jul;117(2-3):275-7. doi: 10.1007/s00439-005-1288-x. Epub 2005 Apr 23.
9
Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse.
Hum Mol Genet. 2010 Feb 15;19(4):634-47. doi: 10.1093/hmg/ddp531. Epub 2009 Dec 16.

引用本文的文献

5
Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT2.
NPJ Parkinsons Dis. 2024 Oct 22;10(1):192. doi: 10.1038/s41531-024-00819-7.
6
High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson's disease.
Proc Natl Acad Sci U S A. 2024 Oct 15;121(42):e2406009121. doi: 10.1073/pnas.2406009121. Epub 2024 Oct 10.
9
Deficiency of Glucocerebrosidase Activity beyond Gaucher Disease: PSAP and LIMP-2 Dysfunctions.
Int J Mol Sci. 2024 Jun 16;25(12):6615. doi: 10.3390/ijms25126615.

本文引用的文献

1
Saposins utilize two strategies for lipid transfer and CD1 antigen presentation.
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4357-64. doi: 10.1073/pnas.1200764109. Epub 2012 Feb 13.
2
A Guided Tour of the Structural Biology of Gaucher Disease: Acid-β-Glucosidase and Saposin C.
Enzyme Res. 2011;2011:973231. doi: 10.4061/2011/973231. Epub 2011 Nov 22.
4
Prosaposin sorting is mediated by oligomerization.
Exp Cell Res. 2011 Oct 15;317(17):2456-67. doi: 10.1016/j.yexcr.2011.07.017. Epub 2011 Jul 29.
5
A mutation in SCARB2 is a modifier in Gaucher disease.
Hum Mutat. 2011 Nov;32(11):1232-8. doi: 10.1002/humu.21566. Epub 2011 Sep 15.
6
Molecular chaperones in protein folding and proteostasis.
Nature. 2011 Jul 20;475(7356):324-32. doi: 10.1038/nature10317.
7
Chronological changes in prosaposin in the developing rat brain.
Neurosci Res. 2011 Sep;71(1):22-34. doi: 10.1016/j.neures.2011.06.001. Epub 2011 Jun 13.
8
X-ray and biochemical analysis of N370S mutant human acid β-glucosidase.
J Biol Chem. 2011 Jan 7;286(1):299-308. doi: 10.1074/jbc.M110.150433. Epub 2010 Oct 27.
9
Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S.
J Biol Chem. 2010 Dec 31;285(53):42105-14. doi: 10.1074/jbc.M110.172098. Epub 2010 Oct 27.
10
The immunological functions of saposins.
Adv Immunol. 2010;105:25-62. doi: 10.1016/S0065-2776(10)05002-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验